Serum brain natriuretic peptide levels may be a useful marker for early diagnosis of cardiomyopathy secondary to neuroblastoma: A case report.

Fujiyama, Natsumi; Matsuo, Osamu; Yamashita, Takahiro; Kohrogi, Kensaku; Miyamura, Fumiya; Anan, Tadashi; Nakamura, Kimitoshi

Fujiyama, Natsumi; Matsuo, Osamu; Yamashita, Takahiro; Kohrogi, Kensaku; Miyamura, Fumiya; Anan, Tadashi; Nakamura, Kimitoshi.

Afiliación

Fujiyama N; Department of Pediatrics, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.
Matsuo O; Department of Pediatrics, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.
Yamashita T; Department of Pediatrics, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.
Kohrogi K; Department of Pediatrics, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.
Miyamura F; Department of Pediatrics, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.
Anan T; Department of Pediatrics, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.
Nakamura K; Department of Pediatrics, Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.

Clin Case Rep ; 12(5): e8738, 2024 May.

Article en En | MEDLINE | ID: mdl-38681045

ABSTRACT

ABSTRACT

Cardiomyopathy is a rare but serious complication associated with neuroblastoma. The brain natriuretic peptide level led to a diagnosis of secondary dilated cardiomyopathy before the worsening of heart failure symptoms.

Palabras clave

BNP; cardiomyopathy; catecholamines; infant; neuroblastoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Case Rep Año: 2024 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google